On Influencing Factors of New Drug Evaluation Project Management in China

Ren Shuang, Dong Lingyun, Zhang Xianglin

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (3) : 288-297.

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (3) : 288-297. DOI: 10.16153/j.1002-7777.2020.03.006
Supervision Administration

On Influencing Factors of New Drug Evaluation Project Management in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 34(3): 288-297 https://doi.org/10.16153/j.1002-7777.2020.03.006

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/